BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 38629624)

  • 1. Quantitative proteomics revealed protein biomarkers to distinguish malignant pleural effusion from benign pleural effusion.
    Dong T; Liang Y; Chen H; Li Y; Li Z; Gao X
    J Proteomics; 2024 May; 302():105201. PubMed ID: 38768894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Regulation of Interleukin-27 in Malignant Pleural Effusion.
    Li S; You WJ; Zhang JC; Zhou Q; Shi HZ
    Chin Med J (Engl); 2015 Jul; 128(14):1932-41. PubMed ID: 26168835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spheroids Generated from Malignant Pleural Effusion as a Tool to Predict the Response of Non-Small Cell Lung Cancer to Treatment.
    Yang TM; Fang YH; Lin CM; Chen MF; Lin CL
    Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine/Chemokine/Growth Factor Levels in Malignant Pleural Effusion of Non-small Cell Lung Cancer.
    Hayama N; Hattori S; Takahashi G; Takahashi F; Takeuchi T; Tanaka J; Horio Y; Takiguchi H; Tomomatsu K; Kitahara A; Takihara T; Niimi K; Oguma T; Asano K
    Tokai J Exp Clin Med; 2020 Dec; 45(4):224-229. PubMed ID: 33300594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients.
    Thompson JC; Fan R; Black T; Yu GH; Savitch SL; Chien A; Yee SS; Sen M; Hwang WT; Katz SI; Feldman M; Vachani A; Carpenter EL
    Lung Cancer; 2019 Jan; 127():25-33. PubMed ID: 30642547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Profiling of Malignant Pleural Effusion in Metastatic Non-Small-Cell Lung Carcinoma. The Effect of Preanalytical Factors.
    Carter J; Miller JA; Feller-Kopman D; Ettinger D; Sidransky D; Maleki Z
    Ann Am Thorac Soc; 2017 Jul; 14(7):1169-1176. PubMed ID: 28557526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
    Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
    Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.
    Tamiya M; Tamiya A; Yasue T; Nakao K; Omachi N; Shiroyama T; Tani E; Hamaguchi M; Morishita N; Suzuki H; Okamoto N; Okishio K; Kawaguchi T; Atagi S; Hirashima T
    Anticancer Res; 2016 Jun; 36(6):2939-44. PubMed ID: 27272808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell transcriptomics reveal metastatic CLDN4+ cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non-small-cell lung cancer.
    Zhang X; Wang X; Wen Y; Chen S; Zhou C; Wu F
    Clin Transl Med; 2024 Apr; 14(4):e1649. PubMed ID: 38629624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel insights into the systemic treatment of lung cancer malignant pleural effusion.
    Tissot C; Gay P; Brun C; Froudarakis ME
    Clin Respir J; 2019 Mar; 13(3):131-138. PubMed ID: 30737898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non‑small cell lung cancer (Review).
    Chen Y; Mathy NW; Lu H
    Mol Med Rep; 2018 Jun; 17(6):8019-8030. PubMed ID: 29693703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of bevacizumab in the management of the patient with malignant pleural effusion: more questions than answers.
    Sabang RL; Gandhiraj D; Fanucchi M; Epelbaum O
    Expert Rev Respir Med; 2018 Feb; 12(2):87-94. PubMed ID: 29235400
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.